Certified by Founder Lodge
4BIO Capital
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $132,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.
4BIO’s objective is to invest in, support, and grow early stage companies developing
| Company | Date | Round | Raised |
|---|---|---|---|
Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
Vianautis |
November, 14 ,2023 | Series A | $25,000,000 |
Actithera |
July, 09 ,2025 | Series A | $75,500,000 |
Ascend Gene & Cell Therapies
Ray Therapeutics, Inc.
Vianautis
Actithera
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Allos | $5,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Juvena Therapeutics | $33,500,000 | (Jan 14, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)